Literature DB >> 8693435

Management of lung cancer in South East Scotland.

R J Fergusson1, A Gregor, R Dodds, G Kerr.   

Abstract

BACKGROUND: There are few reports which describe the management of unselected groups of patients with lung cancer. This study was undertaken to audit prospectively the presentation, diagnosis, management, and outcome of patients presenting with lung cancer in South East Scotland.
METHODS: Data were recorded on all patients with newly diagnosed lung cancer who presented to a multidisciplinary group of clinicians over a 12 month period. Subsequent follow up data on treatment and survival were collected.
RESULTS: Six hundred and twenty two patients were registered, 80% of whom were referred from primary care. There was a considerable variation in the length of history, but the diagnosis was rapidly made after referral (87% within two weeks). In 82% of patients the pathological examination was positive; 70% were treated with palliative intent. Only 36% of patients who underwent surgery had computed tomographic scanning and 55% had sampling of mediastinal nodes. A wide variety of regimens was used for treatment with radiotherapy and chemotherapy, and follow up data were difficult to obtain in these patients. Survival was poor in all patients treated with palliative intent.
CONCLUSIONS: This audit confirms the importance of previously noted prognostic factors. Significant variation in referral practice, diagnostic and management evaluation has been shown. The data serve as a useful background for the formation of local management guidelines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693435      PMCID: PMC1090484          DOI: 10.1136/thx.51.6.569

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.

Authors:  G M Tsang; D C Watson
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

2.  Chemotherapy of non-small cell lung cancer.

Authors:  J G McVie
Journal:  Ann Oncol       Date:  1993-12       Impact factor: 32.976

3.  The value of roentgenologic screening in lung cancer.

Authors:  E Huhti; M Saloheimo; S Sutinen
Journal:  Am Rev Respir Dis       Date:  1983-09

4.  Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983.

Authors:  C K Connolly; W G Jones; J Thorogood; C Head; M F Muers
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

5.  Management of breast cancer in southeast England.

Authors:  A M Chouillet; C M Bell; J G Hiscox
Journal:  BMJ       Date:  1994-01-15

Review 6.  Induction chemotherapy for locally advanced non-small cell lung cancer.

Authors:  F A Shepherd
Journal:  Ann Thorac Surg       Date:  1993-06       Impact factor: 4.330

7.  Radical radiotherapy for carcinoma of the bronchus: an equal alternative to radical surgery?

Authors:  P A Burt; B M Hancock; R Stout
Journal:  Clin Oncol (R Coll Radiol)       Date:  1989-11       Impact factor: 4.126

8.  Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86.

Authors:  S W Watkin; G K Hayhurst; J A Green
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

  8 in total
  13 in total

Review 1.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

2.  Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.

Authors:  G J M Herder; P Verboom; E F Smit; P C M van Velthoven; J H A M van den Bergh; C D Colder; I van Mansom; J C van Mourik; P E Postmus; G J J Teule; O S Hoekstra
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee.

Authors: 
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

Review 4.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

5.  How do general practitioners respond to reports of abnormal chest X-rays?

Authors:  W S Lim; J T Macfarlane; P C Deegan; A Manhire; W F Holmes; D R Baldwin
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

Review 6.  Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:  Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

7.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.

Authors:  A Gregor; C S Thomson; D H Brewster; P L Stroner; J Davidson; R J Fergusson; R Milroy
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

8.  Lung cancer: district active treatment rates affect survival.

Authors:  M L Cartman; A C Hatfield; M F Muers; M D Peake; R A Haward; D Forman
Journal:  J Epidemiol Community Health       Date:  2002-06       Impact factor: 3.710

9.  What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.

Authors:  W Hamilton; T J Peters; A Round; D Sharp
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

10.  Lung cancer referral patterns in the former Yorkshire region of the UK.

Authors:  P P Melling; A C Hatfield; M F Muers; M D Peake; C J Storer; C E Round; R A Haward; S M Crawford
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.